SCHEMBL2472989

SCHEMBL2472989

COc1cc2c(N3CCN(OC(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 19/20 0.81
FLT3 P36888 7/20 0.81
KIT P10721 6/20 0.81
CSF1R P07333 4/20 0.81
PLK4 O00444 1/20 0.81
GAK O14976 1/20 0.81
EPHB6 O15197 1/20 0.81
STK10 O94804 1/20 0.81
EGFR P00533 1/20 0.81
NTRK1 P04629 1/20 0.81
LCK P06239 1/20 0.81
FGFR1 P11362 1/20 0.81
SRC P12931 1/20 0.81
PDGFRA P16234 1/20 0.81
FLT1 P17948 1/20 0.81
FGFR2 P21802 1/20 0.81
FGFR4 P22455 1/20 0.81
FGFR3 P22607 1/20 0.81
AXL P30530 1/20 0.81
FLT4 P35916 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tandutinib SCHEMBL927974 0.90 PDGFRB (1.00) PDGFRBFLT3KITCSF1RPLK4
Tandutinib SCHEMBL29393910 0.90 PDGFRB (1.00) PDGFRBFLT3KITCSF1RPLK4
Tandutinib SCHEMBL2478362 0.89 PDGFRB (0.98) PDGFRBFLT3KITCSF1RPLK4
SCHEMBL13330466 0.89 PDGFRB (1.00) PDGFRBFLT3KITCSF1RPLK4
Tandutinib SCHEMBL2496722 0.86 PDGFRB (0.93) PDGFRBFLT3KITCSF1RPLK4
SCHEMBL13330462 0.86 PDGFRB (1.00) PDGFRBFLT3KITCSF1RPLK4
SCHEMBL22567074 0.85 PDGFRB (0.81) PDGFRBFLT3KITCSF1RPLK4
SCHEMBL13524739 0.84 PDGFRB (0.90) PDGFRBFLT3KITCSF1RPLK4
SCHEMBL13498268 0.83 PDGFRB (0.78) PDGFRBFLT3KITCSF1RPLK4
SCHEMBL13529590 0.83 PDGFRB (0.89) PDGFRBFLT3KITCSF1RPLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370417-A2 LACTATE SALT OF 4-[6-METHOXY-7-(3-PIPERIDIN-1-YL-PROPOXY)QUINAZOLIN-4-YL]PIPERAZINE-1-CARBOXYLIC ACID(4-ISOPROPOXYPHENYL)-AMIDE AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS Millennium Pharmaceuticals, Inc. (US) 2011-10-05 EP disclosed